That was a good laugh Gassin
"It has been successfully piloted in pancreatic and liver cancer. It has clinically demonstrated target tumour regression (tumour shrinkage) in both solid tumour indications of pancreatic and liver cancer."
Where in the world do OSL scientists come from? An amoeba wouldn't come to that conclusion based on those results from a decade ago. Eagerly awaiting the CE mark delay announcement... oh wait, Oncosil doesn't do that, they just pretend it was never submitted and hence never rejected, and then say we'll have the CE mark papers ready for Q1'16. I'll never grow tired of this company, one day there'll be a comedy written about them.
That was a good laugh Gassin "It has been successfully piloted...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |